We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+30.84%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$35.1B
AUM Growth
+$5.1B
Cap. Flow
-$182M
Cap. Flow %
-0.52%
Top 10 Hldgs %
34.5%
Holding
1,568
New
77
Increased
669
Reduced
432
Closed
83

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$126M
2
IBM icon
IBM
IBM
+$74.7M
3
AMD icon
Advanced Micro Devices
AMD
+$67.4M
4
CAT icon
Caterpillar
CAT
+$67.3M
5
ENPH icon
Enphase Energy
ENPH
+$58.4M

Top Sells

Rank Stock Value
1
BE icon
Bloom Energy
BE
+$80.4M
2
AAPL icon
Apple
AAPL
+$67.3M
3
TSM icon
TSMC
TSM
+$62.8M
4
AVGO icon
Broadcom
AVGO
+$56.4M
5
BSX icon
Boston Scientific
BSX
+$54.4M

Sector Composition

Rank Sector Weight
1 Technology 40.59%
2 Healthcare 14.94%
3 Financials 10.55%
4 Communication Services 10.14%
5 Consumer Discretionary 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CXT icon
1201
Crane NXT
CXT
$2.97B
$859K ﹤0.01%
16,800
DAVE icon
1202
Dave Inc
DAVE
$4.8B
$857K ﹤0.01%
2,300
+400
+21% +$104K
GNW icon
1203
Genworth Financial
GNW
$3.81B
$856K ﹤0.01%
90,390
AUGO
1204
Aura Minerals Inc
AUGO
$4.76B
$856K ﹤0.01%
13,600
-2,500
-16% -$197K
CALX icon
1205
Calix
CALX
$2.22B
$855K ﹤0.01%
22,900
+1,800
+9% +$75.5K
GPK icon
1206
Graphic Packaging
GPK
$3.24B
$855K ﹤0.01%
80,852
DEI icon
1207
Douglas Emmett
DEI
$2.02B
$853K ﹤0.01%
72,260
+21,600
+43% +$243K
JOYY
1208
JOYY Inc
JOYY
$3.68B
$851K ﹤0.01%
12,900
+5,200
+68% +$323K
PBH icon
1209
Prestige Consumer Healthcare
PBH
$2.37B
$850K ﹤0.01%
17,981
PATK icon
1210
Patrick Industries
PATK
$2.79B
$849K ﹤0.01%
9,461
OCUL icon
1211
Ocular Therapeutix
OCUL
$1.85B
$848K ﹤0.01%
86,400
+17,100
+25% +$155K
SFNC icon
1212
Simmons First National
SFNC
$3.38B
$848K ﹤0.01%
37,460
UFPT icon
1213
UFP Technologies
UFPT
$1.97B
$848K ﹤0.01%
3,200
ESTA icon
1214
Establishment Labs
ESTA
$2.75B
$841K ﹤0.01%
9,800
+1,000
+11% +$71.8K
RNG icon
1215
RingCentral
RNG
$4.48B
$841K ﹤0.01%
21,570
ACHC icon
1216
Acadia Healthcare
ACHC
$2.62B
$838K ﹤0.01%
28,374
-900
-3% -$23.1K
FCPT icon
1217
Four Corners Property Trust
FCPT
$2.8B
$837K ﹤0.01%
34,095
+600
+2% +$14.9K
VRDN icon
1218
Viridian Therapeutics
VRDN
$2.2B
$834K ﹤0.01%
+45,400
New +$731K
VC icon
1219
Visteon
VC
$2.8B
$829K ﹤0.01%
8,351
ADMA icon
1220
ADMA Biologics
ADMA
$2.01B
$827K ﹤0.01%
98,800
+21,000
+27% +$191K
DOCS icon
1221
Doximity
DOCS
$3.82B
$815K ﹤0.01%
39,300
+2,000
+5% +$44.2K
FSLY icon
1222
Fastly Inc
FSLY
$3.37B
$812K ﹤0.01%
+44,300
New +$963K
CHH icon
1223
Choice Hotels
CHH
$5.08B
$811K ﹤0.01%
7,351
SMMT icon
1224
Summit Therapeutics
SMMT
$10.7B
$809K ﹤0.01%
55,500
+10,900
+24% +$193K
BRC icon
1225
Brady Corp
BRC
$4.39B
$807K ﹤0.01%
8,809

Similar funds

Handelsbanken Fonder's Q2 2026 Portfolio in Review

As of Q2 2026, Handelsbanken Fonder held 1,568 positions worth $35.1B, up 17% from $30B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Handelsbanken Fonder's Q2 2026 filing shows 77 new, 669 increased, 432 reduced and 83 closed positions. Its largest new stake was TE Connectivity: 193,421 shares worth $39M. The largest sale was Bloom Energy, an estimated $80.4M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Handelsbanken Fonder's largest Q2 2026 buy was TE Connectivity: 193,421 shares worth $39M.
  • Handelsbanken Fonder added most to UnitedHealth in Q2 2026, an estimated $126M increase.
  • Handelsbanken Fonder's biggest Q2 2026 reduction was Bloom Energy, cutting an estimated $80.4M.
  • Handelsbanken Fonder fully exited Coca-Cola Europacific Partners in Q2 2026, selling an estimated $30.1M.
  • Handelsbanken Fonder's ten largest holdings make up 34% of its $35.1B portfolio in Q2 2026.
  • Handelsbanken Fonder opened 77 new positions and closed 83 in Q2 2026.
  • Handelsbanken Fonder's portfolio value rose 17% quarter-over-quarter to $35.1B.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.